Socioeconomic status significantly impacts childhood cancer survival in South Africa.
South Africa
childhood cancer outcomes
low- and middle-income country
socioeconomic status
wealth disparity
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
15
08
2023
received:
23
06
2023
accepted:
28
08
2023
pubmed:
14
9
2023
medline:
14
9
2023
entrez:
14
9
2023
Statut:
ppublish
Résumé
Significantly discrepant survival rates have been documented in single disease childhood cancer cohorts in South Africa; those from higher socioeconomic groups were shown to have a significantly lower risk of death than those from less affluent households. This study aimed to determine the impact of socioeconomic status (SES) on childhood cancer survival using pooled South African data. Five databases spanning January 2000 to December 2021 were interrogated. SES status was assigned based on a public sector annual household income classification. H0 households (formally unemployed) received free healthcare. H1, H2 and H3 (annual income > United States Dollar [USD] 19,000) households paid for healthcare relative to their income. The Spearman test assessed correlations between SES and disease stage in patients with solid tumours. Hazard ratios were determined using Cox regression modelling. The Kaplan-Meier procedure estimated overall survival (OS). A total of 1598 children were eligible for analysis; 1269 had a solid tumour with a negative correlation between SES and stage (Spearman rho = -.178; p < .001). Patients with solid tumours and lower SES showed proportionately higher numbers of stage III and IV disease (p < .01). This proportion decreased with higher SES categories. In the multivariate analyses adjusted for sex, age, tumour type and stage, higher SES was associated with lower mortality risk (p < .001), indicating that the impact of SES on survival was in excess of any effect that could be explained by lower stage disease alone. There was a strong positive correlation between race and SES (Fisher's exact tests, p < .001) across all groups and all SES strata. Five-year OS was 85.3% in children from H3 households versus 46.3% in children from H0 households (p < .001). SES significantly impacts childhood cancer survival for children with solid tumours in South Africa. SES is a robust surrogate for race in South Africa as a prognostic metric of disease outcome in childhood cancer. Advocacy to increase social support for impoverished patients is essential to achieve equitable improvements in outcomes treated with standardised national treatment guidelines.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Significantly discrepant survival rates have been documented in single disease childhood cancer cohorts in South Africa; those from higher socioeconomic groups were shown to have a significantly lower risk of death than those from less affluent households. This study aimed to determine the impact of socioeconomic status (SES) on childhood cancer survival using pooled South African data.
METHODS
METHODS
Five databases spanning January 2000 to December 2021 were interrogated. SES status was assigned based on a public sector annual household income classification. H0 households (formally unemployed) received free healthcare. H1, H2 and H3 (annual income > United States Dollar [USD] 19,000) households paid for healthcare relative to their income. The Spearman test assessed correlations between SES and disease stage in patients with solid tumours. Hazard ratios were determined using Cox regression modelling. The Kaplan-Meier procedure estimated overall survival (OS).
RESULTS
RESULTS
A total of 1598 children were eligible for analysis; 1269 had a solid tumour with a negative correlation between SES and stage (Spearman rho = -.178; p < .001). Patients with solid tumours and lower SES showed proportionately higher numbers of stage III and IV disease (p < .01). This proportion decreased with higher SES categories. In the multivariate analyses adjusted for sex, age, tumour type and stage, higher SES was associated with lower mortality risk (p < .001), indicating that the impact of SES on survival was in excess of any effect that could be explained by lower stage disease alone. There was a strong positive correlation between race and SES (Fisher's exact tests, p < .001) across all groups and all SES strata. Five-year OS was 85.3% in children from H3 households versus 46.3% in children from H0 households (p < .001).
CONCLUSION
CONCLUSIONS
SES significantly impacts childhood cancer survival for children with solid tumours in South Africa. SES is a robust surrogate for race in South Africa as a prognostic metric of disease outcome in childhood cancer. Advocacy to increase social support for impoverished patients is essential to achieve equitable improvements in outcomes treated with standardised national treatment guidelines.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e30669Subventions
Organisme : National Research Foundation
ID : CSUR180429324830
Organisme : Harry Crossley Foundation
Organisme : Professor Bongani Mayosi Netcare Clinical Scholarship
Organisme : University of Cape Town
Informations de copyright
© 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
Références
Gini Index-South Africa. The World Bank Group; 2022. Accessed July 15, 2022. https://data.worldbank.org/indicator/SI.POV.GINI?locations=ZA
World Population Review, Gini coefficient by country 2022. World Population Review. Accessed July 15, 2022. https://www.worldpopulationreview.com/country-ranking/gini-coefficient-by-country
Six charts of South Africa's persistent and multi-facted inequality. IMF Press Centre; 2020 [updated January 29, 2020]. Accessed July 15, 2022. https://www.imf.org/en/News/Articles/2020/01/29/na012820six-charts-on-south-africas-persistent-and-multi-facted-inequality
How unequal is South Africa?. Stats SA; 2022. Accessed July 15, 2022. https://www.statssa.gov.za/?p=12930
Ataguba JE, Akazili J, McIntyre D. Socioeconomic-related health inequality in South Africa: evidence from general household surveys. Int J Equity Health. 2011;10:48.
Gordon T, Booysen F, Mbonigaba J. Socioeconomic inequalities in the multiple dimensions of access to healthcare: the case of South Africa. BMC Public Health. 2020;20(1):289.
Levesque JF, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12:18.
Bank TW. The World Bank in South Africa: overview. World Bank; 2023 [updated 30 March 2023]. Accessed August 8, 2023. https://www.worldbank.org/en/country/southafrica/overview
Collingridge D. Cancer, health-care backlogs, and the cost-of-living crisis. Lancet Oncol. 2022;23(6):691.
Sneha LM, Sai J, Ashwini S, Ramaswamy S, Rajan M, Scott JX. Financial burden faced by families due to out-of-pocket expenses during the treatment of their cancer children: an Indian perspective. Indian J Med Paediatr Oncol. 2017;38(1):4-9.
Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817-834.
Boddy-Evans A. South Africa's Apartheid Era Population Registration Act. ThoughtCo.; 2019. Accessed November 4, 2022. https://www.thoughtco.com/population-registration-act-4347313
The Population Registration Act of 1950. South Africa. South Africa History Online; 1950. Accessed June 13. 2023. https://www.sahistory.org.za
Magubane NN. The Experiences of Being Black in the South African Workplace. University of Witwatersrand; 2019.
Samarasekera U. Ntobeko Ntusi: valuing a culture of inclusivity and reciprocity. Lancet North Am Ed. 2022;400(10368):2042.
Winant H. Race and race theory. Annu Rev Sociol. 2000;26:169-185.
Serre D, Paabo S. Evidence for gradients of human genetic diversity within and among continents. Genome Res. 2004;14(9):1679-1685.
Cerdena JP, Grubbs V, Non AL. Racialising genetic risk: assumptions, realities, and recommendations. Lancet. 2022;400(10368):2147-2154.
Yudell M, Roberts D, DeSalle R, Tishkoff S, Science and Society. Taking race out of human genetics. Science. 2016;351(6273):564-565.
Berg KB, Boyer V, Brody J, et al. The use of racial, ethnic, and ancestral categories in human genetics research. Am J Hum Genet. 2005;77(4):519-532.
Geel JA, Chirwa TC, Rowe B, et al. Treatment outcomes of children with Hodgkin lymphoma between 2000 and 2010: first report by the South African Children's Cancer Study Group. Pediatr Blood Cancer. 2017;64(10):e26536.
Van Heerden J, Hendricks M, Geel J, et al. Overall survival for neuroblastoma in South Africa between 2000 and 2014. Pediatr Blood Cancer. 2019;66(11):e27944.
Hendricks M, Cois A, Geel J, et al. Malignant extracranial germ cell tumours: a first national report by the South African Children's Cancer Study Group. Pediatr Blood Cancer. 2022;69(5):e29543.
Schoeman J, Kellerman IM, Ndlovu S, et al. Prevalence of poverty and hunger at cancer diagnosis and its association with malnutrition and overall survival in South Africa. Nutr Cancer. 2023;75(7):1551-1559.
Kehm RD, Spector LG, Poynter JN, Vock DM, Altekruse SF, Osypuk TL. Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival? Cancer. 2018;124(20):4090-4097.
Charlton R, Geel J, Ngcana T. Neuroblastoma survival in South African children is more influenced by biological than socioeconomic factors. S Afr J Oncol. 2022;6(0):a244.
Tolkkinen A, Madanat-Harjuoja L, Taskinen M, Rantanen M, Malila N, Pitkaniemi J. Impact of parental socioeconomic factors on childhood cancer mortality: a population-based registry study. Acta Oncol. 2018;57(11):1547-1555.
Davidson A, Moodley J, Pillay K, Hendricks M, Stewart A, Parkes J. The University of Cape Town's paediatric cancer database: results from the first year (2019-2021). S Afr J Oncol. 2022;6:a234.
Berringer NB, Bennett KG, Poole JE, Geel JA. Determinants of survival in children with cancer in Johannesburg, South Africa. S Afr J Oncol. 2021;5:a189.
Samb B, Desai N, Nishtar S, et al. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet. 2010;376(9754):1785-1797.
Erdmann F, Feychting M, Mogensen H, Schmiegelow K, Zeeb H. Social inequalities along the childhood cancer continuum: an overview of evidence and a conceptual framework to identify underlying mechanisms and pathways. Front Public Health. 2019;7:84.
Braveman P, Egerter S, Williams DR. The social determinants of health: coming of age. Annu Rev Public Health. 2011;32:381-398.
Sweet-Cordero EA, Biegel JA. The genomic landscape of pediatric cancers: implications for diagnosis and treatment. Science. 2019;363(6432):1170-1175.
Lombe DC, Mwamba M, Msadabwe S, et al. Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review. BMJ Open. 2023;13(4):e067715.
Polite BN, Adams-Campbell LL, Brawley OW, et al. Charting the future of cancer health disparities research: a position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. Cancer Res. 2017;77(17):4548-4555.
Mathur R, Rentsch CT, Venkataraman K, et al. How do we collect good-quality data on race and ethnicity and address the trust gap? Lancet. 2022;400(10368):2028-2030.